Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Mallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease 2019-02-21 16:00
Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease 2019-02-21 16:00
Cipla and Wellthy Therapeutics Announce Partnership to Offer Digital Therapeutics for Diabetes and Cardiovascular Diseases 2019-02-21 07:30
Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community shorten the diagnostic odyssey 2019-02-20 19:07
Shanghai Concord Medical Cancer Center's Basic Medical Services have been Fully Covered by Medical Insurance 2019-02-20 17:41
ROKIT Healthcare Announces a Novel Application of Dermal Regeneration Platform Using Proprietary Three-Dimensional Bioprinting Strategy 2019-02-20 13:49
Future of Clinical Laboratories: How to Adapt Your Strategy to the Declining Reimbursements and Be Successful 2019-02-19 21:20
Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method 2019-02-19 21:00
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results 2019-02-19 19:00
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results 2019-02-19 19:00
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo (TM) at WuXi Biologics 2019-02-19 14:21
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo(TM) at WuXi Biologics 2019-02-19 08:21
Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the Combination of Sintilimab, Anti-VEGF Monoclonal Antibody IBI305 in Colorectal Cancer patients 2019-02-18 10:08
Innovent Announces a Collaboration with Chipscreen Biosciences to Evaluate the Combination Therapy in Colorectal Cancer Patients 2019-02-18 08:00
Pivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine 2019-02-18 07:48
New Early Breast Cancer Drug To Be Made Available In Singapore Via Special Access Program 2019-02-18 07:25
Avapritinib receives Phase III clinical trial approval for GIST in China 2019-02-15 23:19
Cyient Recognized as a "Major Contender" in Everest Group's PEAK Matrix(TM): Medical Device Engineering Services Assessment 2019 2019-02-15 16:09
Spring Pharmaceutical Group Inc. Reports Financial Results for the Three and Nine Months Ended December 31, 2018 2019-02-15 05:15
Beijing Intellectual Property Court Confirms Judgment Against Wuxi Hisky Medical for Patent Infringement of Technology Used for Echosens' FibroScan® 2019-02-14 20:02
1 660 661 662 663 664 963